QURE (uniQure N.V.) Stock Market Reviews

crown

search

Read and share opinions on QURE (uniQure N.V.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market.

QURE

uniQure N.V.

clarify Biotechnology

bookmark Healthcare

public Netherlands

Sell Neutral Buy

Latest News

uniQure N.V. (NASDAQ:QURE) Analysts Just Slashed Next Year's Revenue Estimates By 26%
Nov 15, 2025
Analysts Have Lowered Expectations For uniQure N.V. (NASDAQ:QURE) After Its Latest Results
Nov 13, 2025
uniQure (QURE) Surges 17.9% Ahead of 2 Health Conferences
Nov 12, 2025
uniQure NV (QURE) Q3 2025 Earnings Call Highlights: Promising Data Amid Regulatory Challenges
Nov 10, 2025
uniQure (QURE) Is Down 19.0% After FDA Questions Data for AMT-130 Gene Therapy Approval Pathway – Has The Bull Case Changed?
Nov 10, 2025
uniQure (QURE) Reports Q3 Loss, Misses Revenue Estimates
Nov 10, 2025
UniQure: Q3 Earnings Snapshot
Nov 10, 2025
uniQure Announces Third Quarter 2025 Financial Results and Provides Corporate Update
Nov 10, 2025
uniQure to Announce Third Quarter 2025 Financial Results
Nov 6, 2025
A Closer Look at uniQure (QURE) Valuation Following FDA Shift on Huntington’s Gene Therapy Data
Nov 4, 2025
Is Now the Moment to Reassess uniQure After Its 516% Surge and Sharp Drop?
Nov 4, 2025
UniQure Plummets 49% On A 'Confusing' And 'Unexpected' Twist For Its Gene Therapy
Nov 3, 2025
uniQure (QURE) Price Targets Raised by Analysts After Positive Trial Results
Nov 3, 2025
uniQure Provides Regulatory Update on AMT-130 for Huntington’s Disease
Nov 3, 2025

Reviews